{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:19:06Z","timestamp":1790054346701,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T00:00:00Z","timestamp":1394755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.cyto.2014.02.014","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T10:02:13Z","timestamp":1395914533000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis"],"prefix":"10.1016","volume":"67","author":[{"given":"Svitlana","family":"Demyanets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Tentzeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Jarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina M.","family":"Katsaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wonnerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Wojta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter S.","family":"Speidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2014.02.014_b0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrcardio.2011.132","article-title":"Restenosis after PCI. Part 1: pathophysiology and risk factors","volume":"9","author":"Jukema","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cyto.2014.02.014_b0010","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.jacc.2010.06.045","article-title":"The evolving role of inflammatory biomarkers in risk assessment after stent implantation","volume":"56","author":"Niccoli","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2014.02.014_b0015","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.cyto.2014.02.014_b0020","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1161\/01.ATV.0000037100.44766.5B","article-title":"Inflammation and restenosis in the stent era","volume":"22","author":"Welt","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2014.02.014_b0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.atherosclerosis.2009.07.030","article-title":"Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a","volume":"208","author":"Speidl","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2014.02.014_b0030","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1096\/fj.05-4634com","article-title":"Tumor necrosis factor-alpha plays an important role in restenosis development","volume":"19","author":"Monraats","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.cyto.2014.02.014_b0035","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijcard.2007.12.060","article-title":"Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention","volume":"132","author":"Rudolph","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cyto.2014.02.014_b0040","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1161\/01.ATV.0000226544.93089.7f","article-title":"Elevated plasma active matrix metalloproteinase-9 level is associated with coronary artery in-stent restenosis","volume":"26","author":"Jones","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2014.02.014_b0045","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcin.2009.10.023","article-title":"Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9","volume":"3","author":"Katsaros","year":"2010","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.cyto.2014.02.014_b0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1538-7836.2004.01062.x","article-title":"Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medication","volume":"3","author":"Christ","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cyto.2014.02.014_b0055","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1538-7836.2007.02884.x","article-title":"Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents","volume":"6","author":"Katsaros","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cyto.2014.02.014_b0060","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1160\/TH10-09-0566","article-title":"High soluble Fas and soluble Fas Ligand serum levels before stent implantation are protective against restenosis","volume":"105","author":"Katsaros","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cyto.2014.02.014_b0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2014.02.014_b0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.03.020","article-title":"Components of the interleukin-33\/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature","volume":"60","author":"Demyanets","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cyto.2014.02.014_b0075","doi-asserted-by":"crossref","first-page":"e3331","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel \u2018alarmin\u2019?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cyto.2014.02.014_b0080","doi-asserted-by":"crossref","first-page":"i101","DOI":"10.1136\/annrheumdis-2011-200589","article-title":"IL-33: a Janus cytokine","volume":"71","author":"Liew","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2014.02.014_b0085","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.0812690106","article-title":"The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1","volume":"106","author":"Cayrol","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cyto.2014.02.014_b0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","article-title":"Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases","volume":"31","author":"Luthi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2014.02.014_b0095","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/eji.201141668","article-title":"IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma","volume":"41","author":"Eiwegger","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2014.02.014_b0100","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/ATVBAHA.111.224907","article-title":"Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease","volume":"31","author":"Zheng","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2014.02.014_b0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-9255-8-22","article-title":"Role of IL-33 in inflammation and disease","volume":"8","author":"Miller","year":"2011","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.cyto.2014.02.014_b0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2014.02.014_b0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2011.12.010","article-title":"Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis","volume":"58","author":"Xiangyang","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2014.02.014_b0120","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.ijcard.2012.05.073","article-title":"Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?","volume":"167","author":"Dhillon","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cyto.2014.02.014_b0125","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ahj.2011.03.025","article-title":"Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with global registry of acute coronary events risk scoring and NT-proBNP","volume":"161","author":"Dhillon","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.cyto.2014.02.014_b0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations. A review and computer program","volume":"11","author":"Dupont","year":"1990","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cyto.2014.02.014_b0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/039463200902200226","article-title":"The role of interleukin-6 and transforming growth factor-beta1 in predicting restenosis within stented infarct-related artery","volume":"22","author":"Szkodzinski","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.cyto.2014.02.014_b0140","first-page":"623","article-title":"Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting","volume":"67","author":"Zurakowski","year":"2009","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.cyto.2014.02.014_b0145","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/intimm\/dxn060","article-title":"IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells","volume":"20","author":"Smithgall","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.cyto.2014.02.014_b0150","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.4049\/jimmunol.0803067","article-title":"IL-33 enhances lipopolysaccharide-induced inflammatory cytokine production from mouse macrophages by regulating lipopolysaccharide receptor complex","volume":"183","author":"Espinassous","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2014.02.014_b0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.atherosclerosis.2005.03.049","article-title":"Eosinophilic infiltration in restenotic tissue following coronary stent implantation","volume":"184","author":"Rittersma","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cyto.2014.02.014_b0160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2014.02.014_b0165","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1160\/TH11-05-0291","article-title":"Mast cells in atherosclerosis","volume":"106","author":"Bot","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cyto.2014.02.014_b0170","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2014.02.014_b0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2014.02.014_b0180","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1161\/ATVBAHA.111.231431","article-title":"Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques","volume":"31","author":"Demyanets","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cyto.2014.02.014_b0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11010-009-0244-9","article-title":"ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells","volume":"335","author":"Aoki","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.cyto.2014.02.014_b0190","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/156652406778018635","article-title":"Neovascularization in human atherosclerosis","volume":"6","author":"Moreno","year":"2006","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.cyto.2014.02.014_b0195","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2009-02-203372","article-title":"Interleukin-33 induces angiogenesis and vascular permeability through ST2\/TRAF6-mediated endothelial nitric oxide production","volume":"114","author":"Choi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2014.02.014_b0200","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/cvr\/cvr075","article-title":"The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling","volume":"91","author":"Saxena","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cyto.2014.02.014_b0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cyto.2013.03.007","article-title":"Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis","volume":"62","author":"Ishikawa","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2014.02.014_b0210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s10067-011-1686-5","article-title":"Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis","volume":"30","author":"Yanaba","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cyto.2014.02.014_b0215","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1073\/pnas.0912678107","article-title":"Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1\/Th2 driven enteritis","volume":"107","author":"Pastorelli","year":"2010","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614000581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614000581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T23:55:01Z","timestamp":1565308501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1043466614000581"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.02.014","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}